Trade Ideas

Actionable trade ideas with entry/stop/target and risk framing.

Search Articles
Ocugen, Inc. Common Stock
Jan 6, 2026

Ocugen: Why I Keep a Buy - Regulatory Momentum for OCU410ST Backed by Better Cash Position

Actionable trade: buy into regulatory-driven upside with defined risk controls

Ocugen (OCGN) remains a high-risk, high-reward biotech. Recent regulatory chatter around OCU410ST has the stock re-rating potential; combined with a m...

Trade Idea Long
Marvell Technology, Inc. Common Stock
Jan 6, 2026

Marvell (MRVL) - A Tactical Long on the AI Data Path After GPU Excess

Buy the infrastructure rotation: networking and interconnect demand offers a cleaner growth leash than overheated GPU multiples

Marvell is a pure-play data movement specialist positioned to benefit from a shift in AI capex away from oversized GPU multiples and toward high-bandw...

Trade Idea Long
Marvell Technology, Inc. Common Stock
Jan 6, 2026

Marvell: A Tactical Long on an Under-the-Radar Beneficiary of Memory Strength

Solid operating momentum plus a one-time earnings kicker make MRVL a trade worth considering as memory prices bounce.

Marvell (MRVL) has been quietly collecting the benefits of a memory-price upswing through stronger storage and data-center demand. Q3 fiscal 2026 show...

Trade Idea Long
Jan 6, 2026

Buy Brookfield Infrastructure (BIP) Into 2026: Falling Rates + Data Demand Create an asymmetric trade

High-yield, improving dividend trajectory and data-centre exposure make BIP a tactical long with defined entries and stops.

Brookfield Infrastructure (BIP) is a cash-flow heavy infrastructure owner with a growing data segment and a rising quarterly distribution. With the st...

Trade Idea Long
Oruka Therapeutics, Inc. Common Stock
Jan 5, 2026

Oruka (ORKA) - Buy a Phase-2 Runway: ORKA-001 Readout in 2026 Makes a Risk-Reward Case for a Long

Well-funded, loss-making biotech with a p19 psoriasis candidate approaching Phase 2 data - trade the readout with defined risk.

Oruka Therapeutics is a clinical-stage biotech developing IL-23p19 and IL-17A/F antibody programs for psoriasis and related immunology indications. Wi...

Trade Idea Long
Jan 5, 2026

Nebius Upgrade - Bad News Priced In; Risk-Reward Favors a Long Here

Microsoft deal and capacity tailwinds make current levels an asymmetric entry despite execution risks

Nebius (NBIS) has retraced materially from its 12-month highs and is trading near the middle of a volatile range after a period of negative headlines....

Trade Idea Long
Copart Inc
Jan 5, 2026

Copart Still Owns the Salvage Lane — A Tactical Long with Defined Risk/Reward

Market-share durability, high cash conversion and a platform moat make CPRT a pragmatic buy around $38 — trade plan included.

Copart’s online salvage-auction model is cash-generative and insulated by long-term relationships with insurers and a global buyer base. Recent quar...

Trade Idea Long
Valero Energy Corporation
Jan 5, 2026

Valero: Tactical Long After the Venezuelan Supply Shock - A Swing Trade Plan

Capitalize on a geopolitical rerating; buy the refinery leverage, respect the political and margin risks

Valero is trading up sharply after headlines suggesting Venezuelan crude is returning to world markets. Fundamentals look supportive: sequentially imp...

Trade Idea Long
Palomar Holdings, Inc. Common stock
Jan 5, 2026

Palomar (PLMR): Buy on 4Q Outperformance Probability and M&A-Driven Growth

Solid sequential revenue/earnings ramp, cash flow strength and two strategic surety deals make a tactical long—buy on weakness, manage acquisition execution risk

Palomar has shown accelerating top-line and EPS across 2025 quarters, strong operating cash flow, and is actively supplementing organic growth with ta...

Trade Idea Long
Gen Digital Inc. Common Stock
Jan 5, 2026

Gen Digital: A Tactical Long on Cyber Cash Flow + Fintech Upside

Antivirus cash flow funds a fintech push — trade entry, stops and targets for a swing position

Gen Digital is using steady consumer security cash flows to push into fintech after the MoneyLion deal. Revenues jumped to $1.22B in the most recent q...

Trade Idea Long
Caterpillar Inc.
Jan 5, 2026

Caterpillar: Ride the Momentum — Tactical Long with Defined Risk

Big cash flow, steady margins and a rally that still has room — trade it with stops and targets.

Caterpillar (CAT) has ripped higher into year-end on stronger revenues, rising operating income, and heavy operating cash generation. Fundamentals bac...

Trade Idea Long
Jan 5, 2026

ASR Trade Idea - Buy the Midcycle Rebound; Monitor New Concessions and Venezuela Exposure

Swing trade: play steady cash returns and a rerating if new airport wins and Venezuelan lift materialize

Grupo Aeroportuario del Sureste (ASR) offers a pragmatic long setup around current levels. The shares trade near $323.86 on 01/05/2026, comfortably ab...

Trade Idea Long